Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Loh

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2013
In vivo evaluation of axial integrity of coronary stents using intravascular ultrasound: Insights on longitudinal stent deformationDanny Dvir, Hironori Kitabata, Israel M Barbash, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Singapore Medical Journal|February 27, 2015
Effectiveness of early cardiology undergraduate learning using simulation on retention, application of learning and level of confidence during clinical clerkshipsWeiqin Lin, Glenn K Lee, Joshua P Loh, et al.
Cardiovascular Therapeutics|June 7, 2018
Cost-effectiveness analysis of biodegradable polymer versus durable polymer drug-eluting stents incorporating real-world evidenceMonica Teng, Ying Jiao Zhao, Ai Leng Khoo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trialRon Waksman, Antonio Serra, Joshua P Loh, et al.
Cardiovascular Therapeutics|January 10, 2018
A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world populationYing Jiao Zhao, Monica Teng, Ai Leng Khoo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2014
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stentsGabriel L Sardi, Joshua P Loh, Rebecca Torguson, et al.
The Journal of Invasive Cardiology|April 11, 2014
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practiceIsrael M Barbash, Sa'ar Minha, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 17, 2013
Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel diseaseJoshua P Loh, Hironori Kitabata, Rebecca Torguson, et al.
The American Journal of Cardiology|October 9, 2012
Safety and efficacy of everolimus-eluting stents versus sirolimus-eluting stents in womenSalem Badr, Israel M Barbash, Danny Dvir, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2013
In vivo evaluation of axial integrity of coronary stents using intravascular ultrasound: Insights on longitudinal stent deformationDanny Dvir, Hironori Kitabata, Israel M Barbash, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Singapore Medical Journal|February 27, 2015
Effectiveness of early cardiology undergraduate learning using simulation on retention, application of learning and level of confidence during clinical clerkshipsWeiqin Lin, Glenn K Lee, Joshua P Loh, et al.
Cardiovascular Therapeutics|June 7, 2018
Cost-effectiveness analysis of biodegradable polymer versus durable polymer drug-eluting stents incorporating real-world evidenceMonica Teng, Ying Jiao Zhao, Ai Leng Khoo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trialRon Waksman, Antonio Serra, Joshua P Loh, et al.
Cardiovascular Therapeutics|January 10, 2018
A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world populationYing Jiao Zhao, Monica Teng, Ai Leng Khoo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2014
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stentsGabriel L Sardi, Joshua P Loh, Rebecca Torguson, et al.
The Journal of Invasive Cardiology|April 11, 2014
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practiceIsrael M Barbash, Sa'ar Minha, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 17, 2013
Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel diseaseJoshua P Loh, Hironori Kitabata, Rebecca Torguson, et al.
The American Journal of Cardiology|October 9, 2012
Safety and efficacy of everolimus-eluting stents versus sirolimus-eluting stents in womenSalem Badr, Israel M Barbash, Danny Dvir, et al.
Pageof 6